About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Cardiovascular Drugs and Therapy
›
Top Articles
Cardiovascular Drugs and Therapy
Cardiology
,
Pharmacology
3.9
(top 4%)
Impact Factor
4.2
(top 4%)
extended IF
74
(top 5%)
H-Index
1.5K
authors
2.9K
papers
41.6K
citations
3.9K
citing journals
23.6K
citing authors
Most Cited Articles of Cardiovascular Drugs and Therapy
Title
Year
Citations
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study
2005
843
Anthracycline Chemotherapy and Cardiotoxicity
2017
418
Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4
1997
365
Elastic properties and Windkessel function of the human aorta
1995
265
Necrostatin: a potentially novel cardioprotective agent?
2007
251
Phospholipase A2 biochemistry
2009
249
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study
2001
248
Oxygen-derived free radicals and myocardial reperfusion injury: an overview
1991
221
Oxidized LDL, LOX-1 and atherosclerosis
2011
215
Nicotine and sympathetic neurotransmission
1997
184
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
2017
165
Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease
2013
159
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study
2006
156
"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy
1995
156
Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2)
2009
155
Mechanism of cardioprotection by early ischemic preconditioning
2010
153
The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore
2007
136
Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations
1996
126
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher
2016
125
The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy
2006
122
Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study
1990
121
Intima media thickness as a surrogate marker for generalised atherosclerosis
2002
120
The second window of preconditioning (SWOP) where are we now?
2010
117
Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease
2004
115
Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia
1994
115
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.